Biosafety considerations for flow cytometric analysis of human immunodeficiency virus-infected samples.
Schmid
I
I
Department of Hematology and Oncology, University of California at Los Angeles, Los Angeles, California. schmid@mednet.ucla.edu
Kunkl
A
A
Nicholson
J K
JK
D002469:Cell Separation; D003264:Containment of Biohazards / Q000379:methods*; D005434:Flow Cytometry / Q000295:instrumentation / Q000379:methods / Q000592:standards; D015658:HIV Infections / Q000175:diagnosis / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D007755:Laboratories, Hospital / Q000331:legislation & jurisprudence / Q000592:standards*; D016272:Occupational Health; D017751:Safety Management / Q000379:methods / Q000458:organization & administration / Q000592:standards; D013048:Specimen Handling / Q000379:methods / Q000592:standards